Cargando…

An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults

INTRODUCTION: Prevention of infectious diseases in the elderly is essential to establish healthy aging. Yet, immunological aging impairs successful vaccination of the elderly. Predictive biomarkers for vaccine responsiveness in middle-aged adults may help to identify responders and non-responders be...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Heiden, Marieke, Berbers, Guy A. M., Fuentes, Susana, van Zelm, Menno C., Boots, Annemieke M. H., Buisman, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768620/ https://www.ncbi.nlm.nih.gov/pubmed/29375578 http://dx.doi.org/10.3389/fimmu.2017.01962

Ejemplares similares

Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
por: van der Heiden, Marieke, et al.
Publicado: (2018)

Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults
por: van der Heiden, Marieke, et al.
Publicado: (2017)

Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females
por: van der Heiden, Marieke, et al.
Publicado: (2016)

Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands
por: Ohm, Milou, et al.
Publicado: (2020)

Sex-Related Differences in the Immune Response to Meningococcal Vaccinations During Adolescence
por: Ohm, Milou, et al.
Publicado: (2022)

Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2019)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
por: Kaaijk, Patricia, et al.
Publicado: (2012)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

Protection against invasive meningococcal disease and vaccination policy in the Netherlands
por: Ohm, M, et al.
Publicado: (2022)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?
por: Stoof, Susanne P., et al.
Publicado: (2015)

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles
por: van der Lee, Saskia, et al.
Publicado: (2018)

Clinical Spectrum of SCID: The Key is in the Thymus?
por: van der Burg, Mirjam, et al.
Publicado: (2014)

The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment
por: Maiden, Martin Christopher James
Publicado: (2019)

A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines
por: Arunachalam, Arun B., et al.
Publicado: (2022)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity
por: Dowling, David J., et al.
Publicado: (2016)

Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG
por: de Voer, Richarda M., et al.
Publicado: (2011)

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine
por: de Voer, Richarda M., et al.
Publicado: (2010)

Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016)

PID Comes Full Circle: Applications of V(D)J Recombination Excision Circles in Research, Diagnostics and Newborn Screening of Primary Immunodeficiency Disorders
por: van Zelm, Menno C., et al.
Publicado: (2011)

Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals
por: Ispasanie, Emma, et al.
Publicado: (2021)

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
por: Versteegen, Pauline, et al.
Publicado: (2022)

Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience
por: Miller, Jacqueline M., et al.
Publicado: (2011)

Meningococcal Vaccination:: An Update on Meningococcal Vaccine Recommendations for the Primary Care Physician
por: Nichols, Justin, et al.
Publicado: (2022)

Characterization of the early cellular immune response induced by HPV vaccines
por: Pasmans, Hella, et al.
Publicado: (2022)

Editorial: Primary Immunodeficiencies Worldwide
por: van Zelm, Menno C., et al.
Publicado: (2020)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
por: Versteegen, Pauline, et al.
Publicado: (2022)

Meningococcal Vaccines: Challenges and Prospects
por: Bagwe, Priyal, et al.
Publicado: (2020)

Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action
por: Buckley, Paul R., et al.
Publicado: (2019)

Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study
por: Ohm, Milou, et al.
Publicado: (2023)

Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany
por: Elias, Johannes, et al.
Publicado: (2010)

Quantifying Distribution of Flow Cytometric TCR-Vβ Usage with Economic Statistics
por: van der Geest, Kornelis S. M., et al.
Publicado: (2015)

Impact of vaccination on meningococcal epidemiology
por: Stefanelli, Paola, et al.
Publicado: (2015)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Editorial: Nomenclature - Avoiding Babylonian Speech Confusion in Present Day Immunology
por: van Zelm, Menno C., et al.
Publicado: (2020)

Differences in Systemic IgA Reactivity and Circulating Th Subsets in Healthy Volunteers With Specific Microbiota Enterotypes
por: Grosserichter-Wagener, Christina, et al.
Publicado: (2019)

CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?
por: Reitsema, Rosanne D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m957hk2tvs4von2e81ba27op42